Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection
| dc.contributor.author | Moore, Penny L | en_ZA |
| dc.contributor.author | Ranchobe, Nthabeleng | en_ZA |
| dc.contributor.author | Lambson, Bronwen E | en_ZA |
| dc.contributor.author | Gray, Elin S | en_ZA |
| dc.contributor.author | Cave, Eleanor | en_ZA |
| dc.contributor.author | Abrahams, Melissa-Rose | en_ZA |
| dc.contributor.author | Bandawe, Gama | en_ZA |
| dc.contributor.author | Mlisana, Koleka | en_ZA |
| dc.contributor.author | Karim, Salim S Abdool | en_ZA |
| dc.contributor.author | Williamson, Carolyn | en_ZA |
| dc.date.accessioned | 2015-11-18T07:06:55Z | |
| dc.date.available | 2015-11-18T07:06:55Z | |
| dc.date.issued | 2009 | en_ZA |
| dc.description.abstract | Author Summary Most HIV-1 infected individuals develop neutralizing antibodies against their own virus, termed an autologous neutralizing response. It is known that this response exerts pressure on the envelope of HIV, the target of such antibodies, resulting in neutralization escape. Here we have identified the targets of these antibodies and the precise genetic basis of neutralization escape in 4 individuals infected with HIV-1 subtype C. We show that V1V2 is commonly involved in escape, and that the C3 region is also a target in some cases. The latter observation confirms this region is exposed in subtype C, unlike subtype B. We show that neutralization escape is conferred by a few amino acid mutations, some of which are outside the antibody target site. Moreover, escape from these limited specificities even within a single individual occurs via a variety of different pathways involving substitutions, indels and glycan shifts. The finding in 2 individuals that an anti-C3 response developed first, followed by an anti-V1V2 response, suggests there may be specific regions of envelope particularly vulnerable to antibody neutralization. Overall, we propose a mechanistic explanation for how HIV-1 epitopes drive sequential waves of neutralization escape in early subtype C infection. | en_ZA |
| dc.identifier.apacitation | Moore, P. L., Ranchobe, N., Lambson, B. E., Gray, E. S., Cave, E., Abrahams, M., ... Williamson, C. (2009). Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. <i>PLoS One</i>, http://hdl.handle.net/11427/15119 | en_ZA |
| dc.identifier.chicagocitation | Moore, Penny L, Nthabeleng Ranchobe, Bronwen E Lambson, Elin S Gray, Eleanor Cave, Melissa-Rose Abrahams, Gama Bandawe, Koleka Mlisana, Salim S Abdool Karim, and Carolyn Williamson "Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection." <i>PLoS One</i> (2009) http://hdl.handle.net/11427/15119 | en_ZA |
| dc.identifier.citation | Moore, P. L., Ranchobe, N., Lambson, B. E., Gray, E. S., Cave, E., Abrahams, M. R., ... & Morris, L. (2009). Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog, 5(9), e1000598. doi:10.1371/journal.ppat.1000598 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Moore, Penny L AU - Ranchobe, Nthabeleng AU - Lambson, Bronwen E AU - Gray, Elin S AU - Cave, Eleanor AU - Abrahams, Melissa-Rose AU - Bandawe, Gama AU - Mlisana, Koleka AU - Karim, Salim S Abdool AU - Williamson, Carolyn AB - Author Summary Most HIV-1 infected individuals develop neutralizing antibodies against their own virus, termed an autologous neutralizing response. It is known that this response exerts pressure on the envelope of HIV, the target of such antibodies, resulting in neutralization escape. Here we have identified the targets of these antibodies and the precise genetic basis of neutralization escape in 4 individuals infected with HIV-1 subtype C. We show that V1V2 is commonly involved in escape, and that the C3 region is also a target in some cases. The latter observation confirms this region is exposed in subtype C, unlike subtype B. We show that neutralization escape is conferred by a few amino acid mutations, some of which are outside the antibody target site. Moreover, escape from these limited specificities even within a single individual occurs via a variety of different pathways involving substitutions, indels and glycan shifts. The finding in 2 individuals that an anti-C3 response developed first, followed by an anti-V1V2 response, suggests there may be specific regions of envelope particularly vulnerable to antibody neutralization. Overall, we propose a mechanistic explanation for how HIV-1 epitopes drive sequential waves of neutralization escape in early subtype C infection. DA - 2009 DB - OpenUCT DO - 10.1371/journal.ppat.1000598 DP - University of Cape Town J1 - PLoS One LK - https://open.uct.ac.za PB - University of Cape Town PY - 2009 T1 - Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection TI - Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection UR - http://hdl.handle.net/11427/15119 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/15119 | |
| dc.identifier.uri | http://dx.doi.org/10.1371/journal.ppat.1000598 | |
| dc.identifier.vancouvercitation | Moore PL, Ranchobe N, Lambson BE, Gray ES, Cave E, Abrahams M, et al. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS One. 2009; http://hdl.handle.net/11427/15119. | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher | Public Library of Science | en_ZA |
| dc.publisher.department | Institute of Infectious Disease and Molecular Medicine | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_ZA |
| dc.rights.holder | © 2009 Moore et al | en_ZA |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | en_ZA |
| dc.source | PLoS One | en_ZA |
| dc.source.uri | http://journals.plos.org/plospathogens | en_ZA |
| dc.subject.other | Cloning | en_ZA |
| dc.subject.other | Chemical neutralization | en_ZA |
| dc.subject.other | Antibodies | en_ZA |
| dc.subject.other | HIV-1 | en_ZA |
| dc.subject.other | Antibody response | en_ZA |
| dc.subject.other | Viral load | en_ZA |
| dc.subject.other | Antibody specificity | en_ZA |
| dc.subject.other | Glycosylation | en_ZA |
| dc.title | Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Moore_Limited_neutralizing_antibody_2009.pdf
- Size:
- 912.16 KB
- Format:
- Adobe Portable Document Format
- Description: